Phase Ib study of anti-mesothelin antibody drug conjugate anetumab ravtansine in combination with pegylated liposomal doxorubicin in platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 36; no. 15_suppl; p. 5571
Main Authors Bulat, Iurie, Moore, Kathleen N., Haceatrean, Alexei, Chung, John Woojune, Rajagopalan, Prabhu, Xia, Chenghua, Laurent, Dirk, Childs, Barrett H., Santin, Alessandro
Format Journal Article
LanguageEnglish
Published 20.05.2018
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.5571